Alembic Pharmaceuticals face manufacturing disruption in Sikkim due to flash floods

Alembic Pharmaceuticals Limited has faced operational disruptions at its manufacturing facilities in Sikkim, India. The interruption is a result of flash floods in the region, triggered by a cloud burst. 

 

Due to flash floods in the Teesta River, resulting from a cloud burst, water has entered Alembic Pharmaceuticals' manufacturing facility located in Namthang, South Sikkim. As a consequence, manufacturing operations at this facility have been disrupted, starting from October 4, 2023.

 

Fortunately, there have been no reported injuries or harm to any personnel as a result of the flash floods and subsequent operational disruption.

 

While the extent of the loss and damage incurred is yet to be determined, Alembic Pharmaceuticals assures that all assets of the company are adequately insured. The necessary notifications have been made to insurance companies to initiate the assessment and claims process.

 

This development underscores the impact of natural disasters on industrial operations and highlights the need for proactive risk management and contingency planning in the pharmaceutical sector.

 

Alembic Pharmaceuticals Limited remains committed to ensuring the safety of its personnel and the recovery of its manufacturing operations in Sikkim. Further updates on this situation will be provided as and when available.

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Share Market

blog-logo

9 mins read . 11 Oct 2024

Public Sector Undertakings in India

  • 0 people read
blog-logo

Share Market

blog-logo

7 mins read . 11 Oct 2024

How Did Rakesh Jhunjhunwala Become a Billionaire?

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions